Enhancement of mucosal immune responses by intranasal co-delivery of Newcastle disease vaccine plus CpG oligonucleotide in SPF chickens in vivo

Research in Veterinary Science

Volumn 85, Issue 3, 2008, Pages 495-502

  Zhang, Linghua ^a   Zhang, Meirong ^a   Li, Jiaoqing ^a   Cao, Ting ^a   Tian, Xingshan ^b   Zhou, Fengzhen ^b  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF ANIMAL SCIENCE   (China)

Author keywords

CpG ODN; Immune responses; Newcastle disease vaccine; The SPF chickens

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEWCASTLE DISEASE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MUCOSAL IMMUNITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POULTRY FARMING; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; CHICKENS; CYTIDINE MONOPHOSPHATE; GOATS; GUANOSINE; IMMUNITY, MUCOSAL; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; OLIGODEOXYRIBONUCLEOTIDES; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL VACCINES;

ANIMALIA; GALLUS GALLUS; MUS; NEWCASTLE DISEASE VIRUS;

EID: 51049123152     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2008.02.006     Document Type: Article

References (32)

1. Amanda K., and Kenneth L.R. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2. Vaccine 22 (2004) 3098-3104
2. Boyaka P.N., Tafaro A., Fischer R., Fujihashi K., Jirillo E., and McGhee J.R. Therapeutic manipulation of the immune system: enhancement of innate and adaptive mucosal immunity. Current Pharmaceutical Design 9 (2003) 1965-1972
3. Daqing W., Ekambar R.K., Dong Y., Jimmy X.T., and Sudhir A. Oral administration of second-generation immunomodulatory oligonucleotides induces mucosal Th1 immune responses and adjuvant activity. Vaccine 23 (2005) 2614-2622
4. Dalloul R.A., Lillehoj H.S., Okamura M., Xie H., Min W., Ding X., and Heckert R.A. In vivo effects of CpG oligodeoxynucleotide on eimeria infection in chickens. Avian Diseases 48 (2004) 783-790
5. Davis H.L., Suparto I.I., Weeratna R.R., Iskandriati D.D., and Chamzah S.S. CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans. Vaccine 18 (2000) 1920-1924
6. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modification to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunological Methods 89 (1986) 271-277
7. Gomis S., Babiuk L., Godson D.L., Allan B., Thrush T., Townsend H., Willson P., Waters E., Hecker R., and Potter A. Protection of chickens against Escherichia coli infections by DNA containing CpG motifs. Infection and Immunity 71 (2003) 857-863
8. Harandi A.M., and Holmgren J. CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infections. Current Opinion in Investigation Drugs 5 (2004) 141-145
9. Holmgren J., Czerkinsky C., Eriksson K., and Mharandi A. Mucosal immunization and adjuvants: a brief overview of recent advances and challenges. Vaccine 21 Suppl. 2 (2003) 89-95
10. Horner A.A., Ronaghy A., Cheng P.M., Nguyen M.D., Cho H.J., and Broidem D. Immunostimulatory DNA is a potent mucosal adjuvant. Cell Immunology 190 (1998) 77-82
11. Kimman T.G., Sol J., Westenbrink F., and Straver P.J. A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live virus. Veterinary Quarterly 11 (1989) 250-253
12. Klinman D.M., Conover J., and Coban C. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection. Infection and Immunity 67 (1999) 5658-5663
13. Krieg A.M., and Davis H. Enhancing vaccine with immune stimulatory CpG DNA. Current Opinion in Molecular Therapeutics 3 (2001) 15-24
14. Lewis P.J., van Drunen Little-van den Hurk S., and Babiuk L.A. Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. Journal of Virology 73 (1999) 10214-10223
15. Magnusson M., Magnusson S., Vallin H., Ronnblom L., and Alm G.V. Importance of CpG dinucleotides in activation of natural IFN-α producing cells by a lupus-related oligodeoxynucleotide. Scandinavian Journal of Immunology 54 (2001) 543-550
16. Masuda K., Sakaguchi M., Saito S., Deboer D.J., Fujiwara S., Kurata K., Yamashita K., Hasegawa A., Ohno K., and Tsujimoto H. In vivo and in vitro tests showing sensitization to Japanese cedar (Cryptomeria japonica) pollen allergen in atopic dogs. Journal of Veterinary Medical Science 62 (2000) 995-1000
17. McCluskie M.J., and Davis H.L. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. Journal of Immunology 161 (1998) 4463-4466
18. McCluskie M.J., Brazolot Millan C.L., and Gramzinski R.A. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Molecular Medicine 5 (1999) 287-300
19. McCluskie M.J., Weeratna R.D., Payette P.J., and Davis H.L. The potential of CpG oligodeoxynucleotides as mucosal adjuvants. Critical Reviews in Immunology 21 (2001) 103-120
20. McCluskie M.J., Weeratna R.D., Krieg A.M., and Davis H.L. CpG DNA is an effective oral adjuvant to protein antigens in mice. Vaccine 19 (2001) 950-957
21. McGhee J.R., Mestecky J., Dertzbaugh M.T., Eldridge J.H., Hirasawa M., and Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10 (1992) 75-88
22. Michael J.M., Risini D.W., Arthur M.K., and Heather L.D. CpG ODN is an effective oral adjuvant to protein antigens in mice. Vaccine 19 (2001) 950-957
23. Mutwiri G.K., Nichani A.K., Babiuk S., and Babiuk L.A. Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides. Journal of Control Release 97 (2004) 1-17
24. Rankin R., Pontarollo R., Gomis S.M., Karvonen B., Willson P., and Loehr B.I. CpG containing oligodeoxynucleotides augment and switch immune responses of cattle to bovine herpesvirus-1. Vaccine 20 (2002) 3014-3022
25. Staats H.F., Jackson R.J., Marinaro M., Takahashi I., Kiyono H., and McGhee J.R. Mucosal immunity to infection with implications for vaccine development. Current Opinion in Immunology 6 (1994) 572-583
26. Van der Stede Y., Verdonck F., Vancaeneghem S., Cox E., and Goddeeris B.M. CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations. Veterinary Immunology and Immunopathology 86 (2002) 31-41
27. Vleugels B., Ververken C., and Goddeeris B.M. Stimulatory effect of CpG sequences on humoral response in chickens. Poultry Science 81 (2002) 1317-1321
28. Wai M.L., Marcel B.B., and Schutze-Redelmeier M.-P. Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes. Vaccine 20 (2002) 148-157
29. Wang X., Jiang P., Deen S., Wu J., Liu X., and Xu J. Efficacy of DNA vaccines against infectious bursal disease virus in chickens enhanced by coadministration with CpG oligodeoxynucleotide. Avian Diseases 47 (2003) 1305-1312
30. Yamamoto S., Yamamoto T., Nojima Y., Umemori K., Phalen S., McMurray D.N., Kuramoto E., Iho S., Takauji R., Sato Y., Yamada T., Ohara N., Matsumoto S., Goto Y., Matsuo K., and Tokunaga T. Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development. Japanese Journal of Infectious Diseases 55 (2002) 37-44
31. Zhang L.H., Tian X.S., Guo Y., and Zhou F.Z. Effects of CpG ODN on CD4+ and CD8 + T subpopulations in the immune response to porcine reproductive and respiratory syndrome killed virus vaccine. Vaccine 24 (2006) 1874-1879
32. Zhang L.H., Guo Y., Tian X.S., and Zhou F.Z. CpG oligodinucleotides induce strong humoral and cellular responses to swine streptococcic septicemia vaccine in piglets in vivo. International Immunopharmacology 6 (2006) 342-350